


Apremilast Most Helpful for Mild to Moderate Psoriatic Arthritis

Results of SPIRIT: A Head-to-Head Trial of Ixekizumab vs. Adalimumab in Active PsA

Identifying Cardiovascular Risk Factors in Psoriatic Arthritis

Case Report: A Psoriatic Arthritis Patient with Dactylitis & Enthesitis

Psoriatic Arthritis Research Continues Hunt for Biomarkers
